Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1117/week)
Manufacturing
(557/week)
Energy
(421/week)
Technology
(1109/week)
Utilities
(301/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Rigel Pharmaceuticals Inc.
Aug 28, 2019
Rigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference
Aug 06, 2019
Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update
Jun 13, 2019
Rigel to Present Two Posters Highlighting Fostamatinib at the 24 Congress of the European Hematology Association (EHA)
May 31, 2019
Rigel to Present at Jefferies 2019 Healthcare Conference
May 16, 2019
Rigel Enrolls First Patient in Phase 3 Clinical Trial of Fostamatinib Disodium Hexahydrate in Warm Autoimmune Hemolytic Anemia
Apr 30, 2019
Rigel Announces Conference Call and Webcast to Report First Quarter 2019 Financial Results and Company Update
Mar 26, 2019
Rigel Welcomes Jane Wasman to Board of Directors
Feb 28, 2019
Rigel Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
Jan 23, 2019
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe
Jan 07, 2019
Rigel Pharmaceuticals Provides Business Update
Jan 03, 2019
Rigel to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 05, 2018
Rigel to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference in New York City
Nov 06, 2018
Rigel Announces Third Quarter 2018 Financial Results and Provides Company Update
Nov 01, 2018
Rigel to Present Data on Fostamatinib in Three Presentations at the 60th American Society of Hematology Annual Meeting & Exposition
Oct 30, 2018
Rigel Announces Conference Call and Webcast to Report Third Quarter 2018 Financial Results
Oct 29, 2018
Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE(TM) (fostamatinib disodium hexahydrate) in Japan and other Asian Countries
Oct 11, 2018
Rigel Receives EMA Validation of the Marketing Authorization Application for Fostamatinib Disodium Hexahydrate in Chronic Immune Thrombocytopenia (ITP) in Adult Patients
Sep 27, 2018
Rigel to Host Investor & Analyst Day in New York City on October 4, 2018
Sep 24, 2018
Rigel to Present at the Cantor Global Healthcare Conference
Aug 29, 2018
Rigel to Present at the 20th Annual Global Investment Conference in New York City
‹‹
Page 2
››
Latest News
Sep 7, 2025
Missing Canadian soldier found dead in Latvia
Sep 7, 2025
ALIGN PRECISION Appoints Eric Ellis as Chief Executive Officer
Sep 7, 2025
Premier Franchise Management Celebrates New Franchise Signings August 2025
Sep 6, 2025
New Fortress Energy Announces Second Quarter 2025 Results
Sep 6, 2025
AeroVironment, Inc. Chairman, President and CEO to Deliver Keynote Presentation at RBC Capital Markets’...
Sep 6, 2025
New Era Energy & Digital, Inc. Receives Nasdaq Staff Determination Letter
Sep 6, 2025
AIR RACE X - A New Era of Aerial Motorsport, Powered by Cutting-Edge Technology - 2025 Series Finale Decided...
Sep 6, 2025
COLMO EVOLUTION 2.0 Series Wins IFA 2025 Global Innovation Gold Award, Redefining 'Effective Elegance...
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events